Summary by Moomoo AI
Aidigong Maternal and Child Health Co., Ltd. ("Aidigong") announced its interim business performance for the six months ended June 30, 2024. During the reporting period, the company's revenue decreased by 10.6% year-on-year, to approximately 0.275 billion Hong Kong dollars, with a gross margin decreasing from 30.3% to 25.5%, and net loss increased by approximately 16.43 million Hong Kong dollars to around 39.35 million Hong Kong dollars. Both basic and diluted losses per share were 0.81 HK cents. Within the period, Aidigong's postpartum care service business revenue declined, mainly affected by factors such as the depreciation of the Renminbi against the Hong Kong dollar, macroeconomic impacts, and low initial occupancy rates in newly opened postpartum centers. The company proposed a share consolidation plan after the reporting period, which took effect on July 29, 2024, consolidating every 40 existing shares into 1 share. Additionally, on June 20, 2024, the company entered into a subscription agreement with placement agents for a proposed new share placement.
